Group 1: Halozyme Therapeutics - Halozyme Therapeutics is a biopharmaceutical company focused on developing and commercializing novel treatments for oncology by targeting the tumor microenvironment [1] - The company has a Zacks Rank of 1 (Strong Buy) and its current year earnings estimate has increased by 10.5% over the last 60 days [1] - Halozyme's shares have gained 36.2% over the last three months, significantly outperforming the S&P 500's gain of 7.5%, and it possesses a Momentum Score of A [2] Group 2: T. Rowe Price - T. Rowe Price is a global investment management organization offering a wide range of mutual funds, sub-advisory services, and separate account management for various investors [3] - The company also holds a Zacks Rank of 1 and has seen a 9% increase in its current year earnings estimate over the last 60 days [3] - T. Rowe Price's shares have increased by 14.2% over the last three months, again outperforming the S&P 500's gain of 7.5%, and it has a Momentum Score of A [4] Group 3: Cars.com - Cars.com operates an online automotive platform that provides listings for new and used vehicles, along with expert and consumer reviews and research tools [4] - The company has a Zacks Rank of 1 and its current year earnings estimate has risen by 2.3% over the last 60 days [4] - Cars.com's shares have appreciated by 22.3% over the last three months, surpassing the S&P 500's gain of 7.5%, and it also has a Momentum Score of A [5]

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting that price movements should be supported by strong fundamentals and positive earnings estimates [1][2]. Group 1: Stock Performance - Flexible Solutions International Inc. (FSI) has shown a significant price increase of 94.5% over the past 12 weeks, indicating strong investor interest [4]. - FSI's stock has also increased by 57.4% in the last four weeks, suggesting that the upward trend is still intact [5]. - Currently, FSI is trading at 94.6% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - FSI holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like FSI that are on an uptrend with strong fundamentals [3]. - The article suggests that there are multiple stocks passing through this screen, providing additional investment opportunities for trend-focused investors [8].

Core Viewpoint - The sustainability of a stock trend is crucial for successful short-term investing, and various factors must be considered to maintain momentum in stock prices [1][2]. Group 1: Stock Performance - Kiniksa Pharmaceuticals International, plc (KNSA) has shown a solid price increase of 13.3% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also increased by 8.5% in the last four weeks, suggesting that the upward trend is still intact [5]. - KNSA is currently trading at 88.2% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - KNSA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting strong optimism from the brokerage community regarding its near-term price performance [7]. - The Zacks Rank system has a proven track record, with Rank 1 stocks generating an average annual return of +25% since 1988 [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like KNSA that have the fundamental strength to maintain their upward trend [3]. - There are additional stocks that meet the criteria of the "Recent Price Strength" screen, providing further investment opportunities [8]. - The effectiveness of stock-picking strategies can be backtested using the Zacks Research Wizard, which includes successful stock-picking strategies [9].

Core Viewpoint - The article emphasizes the importance of timing and sustainability in stock trends for successful short-term investing, highlighting the need for strong fundamentals to maintain momentum [1][2]. Group 1: Stock Performance - Allot Communications (ALLT) has shown a solid price increase of 34.5% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also increased by 32.5% over the last four weeks, suggesting that the upward trend is still intact [5]. - Currently, ALLT is trading at 80.1% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - ALLT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for investors to identify stocks like ALLT that are on an uptrend supported by strong fundamentals [3]. - The article suggests that there are several other stocks passing through this screen, providing additional investment opportunities [8].

Core Viewpoint - The sustainability of a trend is crucial for successful short-term investing, and confirming fundamental factors is essential to maintain momentum in stocks [1][2]. Group 1: Stock Performance - Mineralys Therapeutics, Inc. (MLYS) has shown a solid price increase of 72.1% over the past 12 weeks, indicating strong investor interest [4]. - The stock has also increased by 23.1% in the last four weeks, suggesting that the upward trend is still intact [5]. - MLYS is currently trading at 83% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - MLYS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks with strong fundamentals that can maintain their upward trends [3]. - In addition to MLYS, there are other stocks that meet the criteria of the "Recent Price Strength" screen, providing additional investment opportunities [8].

Core Viewpoint - The article emphasizes the importance of identifying and maintaining trends in short-term investing, highlighting that sound fundamentals and positive earnings estimates are crucial for sustaining momentum in stock prices [1]. Group 1: Stock Performance - DBV Technologies S.A. (DBVT) has shown a significant price increase of 100.4% over the past 12 weeks, indicating strong investor interest [3]. - The stock has also experienced a price increase of 40.6% over the last four weeks, suggesting that the upward trend is still intact [4]. - Currently, DBVT is trading at 89.5% of its 52-week high-low range, indicating a potential breakout opportunity [4]. Group 2: Fundamental Strength - DBVT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [5]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [6]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like DBVT that have the fundamental strength to maintain their recent uptrend [2]. - There are additional stocks that meet the criteria of the "Recent Price Strength" screen, suggesting further investment opportunities [7].